Quantinno Capital Management LP

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1759654 NEW YORK, NY

Back to UTHR Full portfolio

Position in UTHR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$12,532,632

+$3,929,746 QoQ

Shares Held

21,135

+19.7% QoQ

Ownership

0.050%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Quantinno Capital Management LP holds $190,557,921 across 33 Drug Manufacturers - Specialty & Generic names. UTHR ranks #5 (6.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	1,680,427	$40,212,618
2	ZTS	Zoetis Inc.	330,839	$39,108,478
3	TAK	Takeda Pharmaceutical Co Ltd	1,289,326	$23,878,317
4	VTRS	Viatris Inc	1,161,696	$15,694,512
5	UTHR	UNITED THERAPEUTICS Corp This page	21,135	$12,532,632
6	HLN	Haleon plc	1,221,499	$12,227,204
7	NBIX	Neurocrine Biosciences Inc	69,499	$9,155,798
8	RDY	Dr Reddys Laboratories Ltd	637,094	$8,823,751

All Filings in UTHR

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,532,632	21,135	+19.7%	Shares	Sole	2026-05-15
2025-12-31	$8,602,886	17,656	+82.7%	Shares	Sole	2026-02-17
2025-09-30	$4,050,407	9,662	+136.8%	Shares	Sole	2025-11-14
2025-06-30	$1,172,388	4,080	+34.0%	Shares	Sole	2025-08-14
2025-03-31	$938,682	3,045	+31.8%	Shares	Sole	2025-05-12
2024-12-31	$815,413	2,311	+76.7%	Shares	Sole	2025-02-14
2024-09-30	$468,721	1,308	+32.7%	Shares	Sole	2024-11-14
2024-06-30	$314,090	986	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.